IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
-14.72%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$9.59M
AUM Growth
+$9.59M
(-98%)
Cap. Flow
-$470M
Cap. Flow
% of AUM
-4,907.13%
Top 10 Holdings %
Top 10 Hldgs %
47.01%
Holding
85
New
15
Increased
1
Reduced
62
Closed
7
Top Buys
| 1 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
$620K |
| 2 |
Exelixis
EXEL
|
$350K |
| 3 |
Caribou Biosciences
CRBU
|
$255K |
| 4 |
Galapagos
GLPG
|
$123K |
| 5 |
Ironwood Pharmaceuticals
IRWD
|
$60K |
Top Sells
| 1 |
Dyne Therapeutics
DYN
|
$68.7M |
| 2 |
GMDA
Gamida Cell Ltd. Ordinary Shares
GMDA
|
$61.1M |
| 3 |
Aurinia Pharmaceuticals
AUPH
|
$42.8M |
| 4 |
KalVista Pharmaceuticals
KALV
|
$38.7M |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$20.4M |
Sector Composition
| 1 | Healthcare | 91.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
CRISPR Therapeutics
CRSP
$4.82B
| $34.2K | 0.36% |
+2,078
| New | +$34.2K |
|
52
Apellis Pharmaceuticals
APLS
$3.51B
| $32.5K | 0.34% |
1,470
-31,030
| -95% | -$686K |
|
|
ICPT
53
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $32K | 0.33% |
+441
| New | +$32K |
|
54
NovoCure
NVCR
$1.35B
| $32K | 0.33% |
+2,224
| New | +$32K |
|
55
Sanofi
SNY
$122B
| $31.5K | 0.33% |
1,576
-29,924
| -95% | -$598K |
|
56
Ascendis Pharma
ASND
$12.1B
| $29.4K | 0.31% |
2,733
-26,667
| -91% | -$287K |
|
57
BioNTech
BNTX
$24.1B
| $25.8K | 0.27% |
+3,847
| New | +$25.8K |
|
58
Xenon Pharmaceuticals
XENE
$2.99B
| $25.5K | 0.27% |
774
-24,726
| -97% | -$815K |
|
59
Intellia Therapeutics
NTLA
$1.26B
| $24K | 0.25% |
1,242
-22,758
| -95% | -$440K |
|
60
Regeneron Pharmaceuticals
REGN
$59.8B
| $23.7K | 0.25% |
14,010
+1,910
| +16% | +$3.23K |
|
61
Beam Therapeutics
BEAM
$1.9B
| $23.5K | 0.25% |
+910
| New | +$23.5K |
|
62
Agios Pharmaceuticals
AGIO
$2.36B
| $21.5K | 0.22% |
476
-21,024
| -98% | -$950K |
|
63
PTC Therapeutics
PTCT
$4.41B
| $21K | 0.22% |
842
-410,158
| -100% | -$10.2M |
|
64
United Therapeutics
UTHR
$17.7B
| $20K | 0.21% |
4,713
-15,287
| -76% | -$64.9K |
|
|
BPMC
65
DELISTED
Blueprint Medicines
BPMC
| $19.5K | 0.2% |
985
-18,515
| -95% | -$367K |
|
66
Jazz Pharmaceuticals
JAZZ
$7.99B
| $17.2K | 0.18% |
2,683
-14,517
| -84% | -$93.1K |
|
|
SWTX
67
DELISTED
SpringWorks Therapeutics
SWTX
| $16.3K | 0.17% |
401
-15,899
| -98% | -$646K |
|
68
Protagonist Therapeutics
PTGX
$3.62B
| $16.2K | 0.17% |
+128
| New | +$16.2K |
|
|
ONC
69
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| $15.7K | 0.16% |
2,542
-13,158
| -84% | -$81.3K |
|
70
Prothena Corp
PRTA
$452M
| $15K | 0.16% |
407
-14,593
| -97% | -$538K |
|
71
Axsome Therapeutics
AXSM
$6.09B
| $14K | 0.15% |
535
-13,465
| -96% | -$352K |
|
|
KRTX
72
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $12.4K | 0.13% |
+1,567
| New | +$12.4K |
|
73
Relmada Therapeutics
RLMD
$48.8M
| $10K | 0.1% |
190
-9,810
| -98% | -$516K |
|
74
AnaptysBio
ANAB
$630M
| $10K | 0.1% |
203
-9,797
| -98% | -$483K |
|
75
Madrigal Pharmaceuticals
MDGL
$9.7B
| $5.35K | 0.06% |
383
-4,967
| -93% | -$69.4K |
|